LYRA - Financial Reports List - Lyra Therapeutics, Inc. - IntrinsicAlpha

Lyra Therapeutics, Inc. LYRA

Healthcare - Biotechnology - NASDAQ - US

$ 0.093

0.925 %

$ 6.13 M

Market Cap

-0.06

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	43.15%	27.56%	30.76%
Annual Report	FY	10-K	2024-12-31	-1.54%	-49.07%	-43.55%
Quarterly Report	Q3	8-K	2024-09-30	-64.15%	24.14%	26.06%
Quarterly Report	Q2	8-K	2024-06-30	30.57%	-208.18%	-196.76%
Quarterly Report	Q1	8-K	2024-03-31	29.76%	-38.12%	-35.87%
Quarterly Report	Q4	8-K	2023-12-31	1227.27%	-6.47%	-8.72%
Annual Report	FY	10-K	2023-12-31	14.31%	-13.39%	-19.21%
Quarterly Report	Q3	8-K	2023-09-30	51.53%	-5.99%	-13.50%
Quarterly Report	Q2	8-K	2023-06-30	12.53%	-8.34%	-13.67%
Quarterly Report	Q1	8-K	2023-03-31	-92.36%	-132.28%	-146.41%

1